Literature DB >> 10932598

Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.

G Rindi1, C Capella, E Solcia.   

Abstract

A revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract has been recently developed under the auspices of the World Health Organization (WHO) according to advances in the field of tumor biology. Here the classification is briefly outlined and discussed together with the guidelines for a correct approach to the histopathological diagnosis of neuroendocrine tumors and the interpretation of the classification schemes covering clinical (hyperfunctional syndromes included), pathological and biological patterns, with special emphasis on tumor prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10932598

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN: 1125-0135


  15 in total

1.  Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.

Authors:  Martijn van Essen; Eric P Krenning; Willem H Bakker; Wouter W de Herder; Maarten O van Aken; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-27       Impact factor: 9.236

2.  Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.

Authors:  Robert C G Martin; David A Kooby; Sharon M Weber; Nipun B Merchant; Alex A Parikh; Clifford S Cho; Syed A Ahmad; Hong Jin Kim; William Hawkins; Charles R Scoggins
Journal:  J Gastrointest Surg       Date:  2010-11-20       Impact factor: 3.452

Review 3.  Diagnosis and treatment of gastric neuroendocrine tumours.

Authors:  Ursula Plöckinger
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 4.  Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Authors:  Skye C Mayo; Joseph M Herman; David Cosgrove; Nik Bhagat; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-10-11       Impact factor: 6.113

5.  Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.

Authors:  Timothy R Donahue; Kevork K Kazanjian; William H Isacoff; Howard A Reber; O Joe Hines
Journal:  J Gastrointest Surg       Date:  2010-03-23       Impact factor: 3.452

6.  Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum.

Authors:  Bun Kim; Ji Hye Huh; Youngsook Kim; Moon Jae Chung; Jeong Youp Park; Si Young Song; Seung Woo Park
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

Review 7.  Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.

Authors:  Mina Jamali; Runjan Chetty
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

8.  Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors.

Authors:  Narek Shaverdian; Scott N Pinchot; Barbara Zarebczan; Holly C Gillis; Adam Schiro; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2012-09-01       Impact factor: 5.344

9.  Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater.

Authors:  Joanna A Musialik; Maciej J Kohut; Tomasz Marek; Anatol Wodołazski; Marek Hartleb
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

10.  ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours.

Authors:  Rajaventhan Srirajaskanthan; A Ahmed; A Prachialias; P Srinivasan; N Heaton; N Jervis; A Quaglia; G Vivian; J K Ramage
Journal:  ISRN Oncol       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.